-

Auna Announces Reporting Dates for Third Quarter 2025 Financial Results

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Third Quarter 2025 financial results.

Earnings Release
Thursday, November 20, 2025
Time: After Market Close

Conference Call
Friday, November 21, 2025
Time: 8:00 a.m. ET

Quiet Period
Thursday, November 13 through Thursday, November 20, 2025

To participate, please dial
+1 888 596 4144 (Toll-Free)
+1 646 968 2525 (International)
Entry Passcode: 3884034
Webcast: click here

About Auna

Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, focusing on high-complexity diseases. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering in the underpenetrated markets of Spanish-speaking Americas. Founded in 1989, Auna has built one of Latin America′s largest modern healthcare platforms that consists of a horizontally integrated network of healthcare facilities and a vertically integrated portfolio of oncological plans and selected general healthcare plans. As of June 30th, 2025, Auna’s network included 31 healthcare network facilities, including hospitals, outpatient, prevention and wellness facilities with 2,333 beds, and 1.4 million healthcare plans. For more information visit www.aunainvestors.com

Contacts

Investor Relations Contact
contact@aunainvestors.com

Industry:

Auna S.A.

NYSE:AUNA
Release Versions
English

Contacts

Investor Relations Contact
contact@aunainvestors.com

More News From Auna S.A.

Auna Announces Completion of US$765 million Debt Refinancing

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (“Auna” or the “Company”), a leading healthcare services provider in Latin America with operations in Mexico, Peru, and Colombia, announced today the closing of a US$765 million debt refinancing that significantly strengthens its capital structure by extending debt maturities, lowering interest expenses, and improving cash flow generation to further invest in the Company’s various strategic growth initiatives. The Company and Oncosalud S.A.C., as co-issuer...

Auna Announces Successful Pricing of 8.750% Senior Secured Notes Due 2032

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced the pricing of U.S.$365,000,000 aggregate principal amount of 8.750% Senior Secured Notes due 2032 (the “Notes”) to be issued by the Company and Oncosalud S.A.C. (“Oncosalud” and, together with the Company, the “Co-Issuers”), as co-issuers, which includes (i) U.S.$328,500,000 in aggregate principal amount of Notes offere...

Auna S.A. Announces Early Results of Its Cash Tender Offer and Related Consent Solicitation of Any and All of Its Outstanding 10.000% Senior Secured Notes Due 2029

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA), a public limited liability company (société anonyme) incorporated and existing under the laws of Luxembourg, having its registered office at 6, rue Jean Monnet, L-2180 Luxembourg, and registered with the Luxembourg Trade and Companies Register (Registre de Commerce et des Sociétés, Luxembourg) under number B267590 (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the e...
Back to Newsroom